Megan Wetzel, Vice President of Product, Access & Affordability at CoverMyMeds, explores how tailored, lifecycle-specific access strategies help patients start and stay on therapy amid affordability challenges.
Megan Wetzel, Vice President of Product, Access & Affordability
Advertisement
Articles by Megan Wetzel, Vice President of Product, Access & Affordability
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Roche Announces Positive Topline Results from Phase II Study for Dual GLP-1/GIP Receptor Agonist
2
Boehringer Ingelheim Enters $1.26 Billion Collaboration and License Agreement with Simcere Pharmaceuticals to Develop Pre-Clinical Bispecific Antibody
3
Pharmaceutical Executive Daily: Roche Reports Positive Phase II Study Results for Dual GLP-1/GIP Receptor Agonist
4
Rethinking Tail Spend: Transforming Procurement Before Compliance Risks Escalate
5